drugset / Trial / NCT01878669

Effects of N-acetyl Cysteine During Percutaneous Coronary Intervention

NCT01878669

Phase 3 Active not recruiting 390 enrolled Suleyman Demirel University
RandomizedParallel-groupTriple-blindPrevention

Summary

The aim of this study is to evaluate the effects of N-acetyl cysteine on periprocedural myocardial infarction and major cardiac and cerebral events in patients undergoing percutaneous coronary intervention and who have moderate to high risk for contrast induced nephropathy.

Timeline

Start
2013-01
Primary completion
2017-09
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Subject N-acetylcysteine Small molecule 50 mg/kg Intravenous